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Abstract
Background: The thymus is a central lymphoid organ, in which bone marrow-derived T cell precursors undergo a
complex process of maturation. Developing thymocytes interact with thymic microenvironment in a defined spatial
order. A component of thymic microenvironment, the thymic epithelial cells, is crucial for the maturation of
T-lymphocytes through cell-cell contact, cell matrix interactions and secretory of cytokines/chemokines. There is
evidence that extracellular matrix molecules play a fundamental role in guiding differentiating thymocytes in both
cortical and medullary regions of the thymic lobules. The interaction between the integrin a5b1 (CD49e/CD29;
VLA-5) and fibronectin is relevant for thymocyte adhesion and migration within the thymic tissue. Our previous
results have shown that adhesion of thymocytes to cultured TEC line is enhanced in the presence of fibronectin,
and can be blocked with anti-VLA-5 antibody.
Results: Herein, we studied the role of CD49e expressed by the human thymic epithelium. For this purpose we
knocked down the CD49e by means of RNA interference. This procedure resulted in the modulation of more than
100 genes, some of them coding for other proteins also involved in adhesion of thymocytes; others related to
signaling pathways triggered after integrin activation, or even involved in the control of F-actin stress fiber
formation. Functionally, we demonstrated that disruption of VLA-5 in human TEC by CD49e-siRNA-induced gene
knockdown decreased the ability of TEC to promote thymocyte adhesion. Such a decrease comprised all CD4/CD8-
defined thymocyte subsets.
Conclusion: Conceptually, our findings unravel the complexity of gene regulation, as regards key genes involved
in the heterocellular cell adhesion between developing thymocytes and the major component of the thymic
microenvironment, an interaction that is a mandatory event for proper intrathymic T cell differentiation.
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The thymus is a central lymphoid organ, in which bone
marrow-derived T cell precursors undergo a complex
process of maturation, eventually leading to the migra-
tion of positively selected thymocytes to the T-depen-
dent areas of peripheral lymphoid organs. This
differentiation process involves sequential expression of
a variety of membrane proteins and rearrangements in
T-cell receptor genes. Most potentially self-reactive thy-
mocytes are negatively selected by clonal deletion,
whereas some are rescued from death through positive
selection, eventually yielding the vast majority of the T-
cell repertoire [1]. In both positive and negative selec-
tion events, cell-cell adhesion between developing thy-
mocytes and non-lymphoid microenvironmental cells of
the organ is mandatory [1].
The thymic microenvironment which is tridimensional
network composed of non-lymphoid cells including thy-
mic epithelial cells (TEC) – the most conspicuous cellu-
lar elements – dendritic cells, macrophages and, to a
lesser extent fibroblasts, as well as extracellular matrix
(ECM) [2,3]. Developing thymocytes interact with thy-
mic microenvironment in a defined spatial order. This is
evident from the different localization of the individual
stages of thymocyte development. The most immature,
CD4
-CD8
- double negative (DN) thymocytes are found
beneath the subcapsular epithelium of the thymic
lobules, while the more mature, CD4
+CD8
+ double posi-
tive (DP) stages can be detected throughout the cortical
region. The more differentiated CD4
+ or CD8
+ single
positive (SP) thymocytes are mainly found in the
medulla [2]. There is evidence that extracellular matrix
(ECM) molecules play a fundamental role in localizing
the different thymocyte stages in the thymus [4]. Inter-
estingly, it is possible that supramolecular ECM arrange-
ments function as a conveyor belt, allowing an ordered
migration of thymocytes within the organ [5].
Fibronectin (FN) is one ECM ligand constitutively
expressed in all mammalian thymuses so far analyzed,
including mice and humans [6-8]. Particularly in the
human thymus both FN isoforms were detected within
the thymic lobules [9]. Two integrin-type fibronectin
specific receptors are consistently expressed by develop-
ing thymocytes: VLA-5 (a5b1, CD49e/CD29), which
recognizes the RGD-containing fibronectin binding site
and VLA-4 (a4b1, CD49d/CD29) that identify the CS1
segment of fibronectin, derived by alternative splicing of
the corresponding pre-mRNA [10]. VLA-4 is expressed
on almost all human thymocytes (98%). Its membrane
expression is higher on DN thymocytes, decreases
slightly on DP cells, and is 10-fold lower on SP cells.
Although VLA-5 is also expressed by the majority of
thymocytes (60 to 70%), its expression pattern is distinct
from that a4b1: it is expressed at high levels on DN
cells, decreases on DP cells, but it is up-regulated on
mature single positive cells [11].
Thymic microenvironmental cells express integrin-
type fibronectin receptors [4]. In cultured human TEC,
both VLA-4 and VLA-5 were detected [12,13]. In the
mouse model, we demonstrated that both epithelial and
non-epithelial phagocytic cells of the thymic microenvir-
onment express VLA-5 at high densities on their mem-
branes [4,14]. In all cases, the interaction between a5b1
and FN is essential for thymocyte adhesion to microen-
vironmental cells, since heterocellular adhesion could be
significantly disrupted by using anti-VLA-5 antibody
applied to growing TEC prior to co-culturing with thy-
mocytes [13-15].
Herein, we further studied the role of integrin a5 sub-
unit in human thymocyte and thymic epithelial cell
interactions, through the silencing of the gene coding
for CD49e, a5 integrin subunit of VLA-5, in thymic
epithelial cells by RNA interference (RNAi), an approach
that has emerged as a convenient and effective tool for
loss-of-function studies. Using this strategy, we looked
for differential gene expression in silenced cells using
cDNA microarrays. CD49e gene silencing yielded a
modulation of more than 100 genes, including adhesion
molecules and some genes related to integrin pathway.
Following transfection of cultured TEC with CD49e spe-
cific RNAi, we also found that the reduction in VLA-5
density on TEC membrane significantly decreased thy-
mocyte adhesion. Conjointly, our data reinforce the role
of VLA-5 in TEC/thymocyte interactions in the process
of human thymocyte differentiation.
Results
Inhibition of CD49e expression by siRNA in human
thymic epithelial cells
We first defined if we could effectively silence CD49e
mRNA and the corresponding protein using small inter-
ference RNA (siRNA) in human TEC preparations,
known to constitutively express a5b1a sw e l la sa4b1
fibronectin receptors [12]. For that, we transfected into
the human TEC line a CD49e-siRNA that is comple-
m e n t a r yt ot h eC D 4 9 eg e n eo rac o n t r o ls c r a m b l e d
siRNA, both conjugated to alexa-488 (applied herein for
evaluating the efficacy of transfection). As assessed after
24 hours of transfection in a dose curve by flow cytome-
try, TECs exhibited 80% of alexa-488 expression com-
pared to labeling seen in untransfected cells in 2.5nM of
siRNA (data not shown). The down-regulation of
CD49e mRNA induced by siRNA was determined using
real-time quantitative PCR. The total level of CD49e
mRNA could be reduced as much as 100% on CD49e-
siRNA compared to control-siRNA cells, 48 hours
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Page 2 of 13following transfection (Figure 1A), although the reduc-
tion degree could vary from experiment to experiment,
in a range between 40 to 100% of mRNA silencing. To
determine whether expression of the CD49e integrin
subunit was suppressed on the cell surface of TEC line
following transfection with CD49e-siRNA cells were
stained with a monoclonal CD49e-specific antibody con-
jugated to phycoeritrin. A distinct subpopulation with
reduced levels of surface CD49e was clearly resolved
using flow cytometry in the CD49e-siRNA sample but
not in the control sample (Figure 1B). The same result
was found by immunofluorescence, transfected cells
were stained with the same CD49e-antibody used in
flow cytometry 72 hours following transfection. CD49e-
siRNA treated cells showed reduction of a5i n t e g r i n
subunit compared to control siRNA transfected cells
(Figure 1D).
A time-course evaluation revealed that CD49e-siRNA-
triggered down-regulation of membrane CD49e was
transient with most efficient silencing at 72h post-trans-
fection (Figure 1C). Reduced membrane levels of CD49e
were not detected earlier than 48h indicating that
CD49e specific siRNA treatment requires days to effec-
tively suppress protein expression.
Specificity of siRNA-mediated silencing
We next investigated whether the surface expression of
other integrin-type fibronectin receptor was altered in
CD49e-siRNA transfected cells. For that, we analyzed
the cell surface expression of CD49d that together
with CD29 form the integrin a4b1( V L A - 4 ) .T h r e e
days following transfection, cells were labeled with
anti-CD49d and anti-CD49e monoclonal antibodies
and analyzed by flow cytometry. A decrease on the
surface expression of CD49e receptor was confirmed,
but no significant differences in the cell surface expres-
sion of CD49d was observed (Figure 2A). Of note, we
also analyzed the gene expression of integrin b1
control scramble-siRNA CD49e-siRNA
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Figure 1 Knockdown of CD49e gene in human thymic epithelial cells by RNA interference. Panel A depicts the expression of CD49e
mRNA determined by realtime quantitative PCR 48 hours after CD49e-siRNA or scramble-siRNA transfection. Results were normalized to b-
glucuronidase mRNA and are expressed relative to the mRNA levels in untreated (non-transfected) cells. Data are representative of three
independent experiments performed in triplicate. Bars represent the mean ± SEM; the differences between groups were validated using the
Student’s t test (p < 0.009). Panel B shows flow cytometry profiles of human TEC cultures, for immunochemical detection of CD49e using a
specific anti-CD49e monoclonal antibody, 72 hours post-transfection with either scramble-siRNA (gray curve) or CD49e-siRNA (white curve with
black contour). The open curve with gray line on the left corresponds to the fluorescence levels elicited by an unrelated isotype matched
monoclonal antibody. These plots are representative of four independent experiments. In panel C, a kinetic flow cytometry analysis reveals the
transient decrease on the membrane expression of CD49e, in cultured human, TEC 48, 72, 96 or 120 hours post-transfection with CD49e-siRNA.
Panel D reveals immunofluorescence images for detection of CD49e (using the anti-CD49e monoclonal antibody) in human TEC cultures, 72
hours post-transfection with scramble-siRNA or CD49e-siRNA. On the left side of the panel, an untreated TEC culture was submitted to the same
immunofluorescence assay. Bars = 20 µm.
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Figure 2 Specificity of CD49e gene silencing using RNA interference in cultured human thymic epithelial cells. Panel A shows
cytofluorometric profiles for membrane detection of CD49e (left panels) and CD49d (a4 integrin chain, right panels) subunits of fibronectin
receptors in control, scramble-siRNA and CD49e-siRNA transfected cultured human thymic epithelial cells. There is no change for CD49d
expression (red line), although the expression of CD49e is clearly –down-regulated in CD49e-siRNA transfected cells (red line). The vertical black
lines were inserted so that to make clearer that membrane levels of CD49e (but not CD49d) were decreased in CD49e-siRNA transfected TEC.
Open peaks show the fluorescence signal generated when cells were subjected to the unrelated isotype-matched monoclonal antibody. Panel B
reveals that there are no changes in the expression of CD29 (b1 integrin subunit) mRNA, as determined by real-time quantitative PCR 48 hours
after transfection. Results were normalized to b-glucuronidase mRNA and are expressed relative to the mRNA levels seen in scramble-siRNA
transfected cells. Data seen in this panel are representative of three independent experiments performed in triplicate. Panels C and D show the
expression of fibronectin at the mRNA and protein levels respectively. Although the mean levels of mRNA (defined by qPCR) was lower in
CD49e-siRNA versus scramble-siRNA transfected cultured TEC, such different was not statistically significant, and the levels of the corresponding
protein, herein defined by immunohistochemistry, were similar in both groups (D). Panel D reveals immunofluorescence images for detection of
fibronectin (using the anti-fibronectin monoclonal antibody) in human TEC cultures, 72 hours post-transfection with scramble-siRNA or CD49e-
siRNA. On the left side of the panel, an untreated TEC culture was submitted to the same immunofluorescence assay. Bars = 20 μm.
Linhares-Lacerda et al. BMC Genomics 2010, 11(Suppl 5):S2
http://www.biomedcentral.com/1471-2164/11/S5/S2
Page 4 of 13subunit (CD29) by real-time quantitative PCR and
there was no reduction of gene expression levels when
compared scramble-siRNA versus CD49e-siRNA trans-
fected cells (Figure 2B). Also, fibronectin expression, at
both mRNA and protein levels, was not significantly
changed (Figure 2C-D).
Conjointly, these data tell us that CD49e-siRNA speci-
fically repress the expression of the corresponding gene,
but does not interfere with the expression of its natural
ligand, fibronectin, neither to the expression of the
other integrin-type fibronectin receptor, VLA-4.
Nevertheless, real-time quantitative PCR analysis
revealed that members of other adhesion receptor gene
families were modulated. This was the case for neuronal
cell adhesion molecule, as well as neuropilin-2 and its
corresponding signaling transducer plexin A1. Interest-
ingly, gene expression of another natural neuropilin
ligand, VEGF, was also down-regulated in CD49e-siRNA
treated TEC, as compared to control scramble-siRNA
treatment (Figure 3).
Finally, we found that gene expression of one member
of the integrin signaling cascade, phosphatidylinositol-4-
phosphate 5-kinase (PIP5K), was down-regulated in
CD49e-siRNA treated TEC.
Gene expression profile in CD49e RNA silenced
human TEC
The above findings, together with previous data showing
that blockade of CD49e with a specific antibody directly
stimulated the production of both TGF-b (transforming
growth factor-b) and PAI-1 (plasminogen activator inhi-
bitor-1) in human mesangial cells [16], led us to further
explore the effect of CD49e gene silencing in cultured
TEC, using DNA microarray strategy. The relative abun-
dance of each transcript was analyzed 48 hours after
transfection. Three independent experiments were per-
formed and the efficiency of CD49e depletion was con-
firmed by real-time quantitative PCR (Figure 1A). The
microarray analysis identified 131 genes differentially
expressed following knockdown of the CD49e gene,
when compared with TEC cultures treated with scram-
ble-siRNA. Among these, 65 genes were down-regulated
and 66 genes were up-regulated (see each gene sepa-
rately in Additional file 1 and 2).
The differential expressed genes were classified in
categories according to biological function (Figure 4).
Among the 65 down-regulated genes, 6% corresponded
to those reported above, concerning cell adhesion mole-
cules. Genes related to signal transduction and tran-
scription factors represented 9% and 6% of the down-
regulated genes, whereas 6% were related to protein
metabolism, and 5% to intracellular transport. Neverthe-
less, 60% of the down-regulated genes are still not
annotated.
As shown in figure 4, among the 66 up-regulated
genes, 44% are not yet annotated, and 23% belong to
the functional category of signal transduction. Some of
these genes, like phospholipase Cg1 (PLCg1), cysteine-
rich PAK1 inhibitor (CRIPAK), V-raf murine sarcoma
viral oncogene homolog B1 (B-raf) and SHC (Src
homology 2 domain containing) transforming protein 1
(SHC1), are involved in the integrin signaling pathway,
thus suggesting the existence of compensatory mechan-
isms taking place within the integrin-related circuitry.
RNAi mediated loss of CD49e expression leads to a
decrease in TEC/ Thymocyte adhesion
In a last set of experiments, we addressed the functional
consequences of CD49e-siRNA-triggered down-regula-
tion of CD49e expression in TEC, upon their ability to
interact with developing thymocytes. For this purpose,
we evaluated thymocyte adhesion in TEC transfected
with CD49e-siRNA versus untreated or scramble-siRNA
treated. Thus, CD49e-siRNA transfected cells had
decreased number of adhered thymocytes compared to
cells transfected with scramble-siRNA or untreated cells
(Figure 5A-B).
It is noteworthy that, although a precise quantitative
analysis was not done, we did not notice any clear-cut
change in TEC growth, with cultures being rather simi-
lar among the various groups.
We then evaluated whether adhesion blockade tar-
geted preferentially a given CD4/CD8-defined thymocyte
subset (Figure 5C). This was not the case, since all
immature and mature subsets were similarly affected
a f t e ra d h e s i o ni nC D 4 9 e - s i R N A ,w h e nc o m p a r e dt o
scramble-siRNA or untreated cells.
Taken together, our observations confirm the impor-
tance of the fibronectin receptor VLA-5 in TEC/thymo-
cyte adhesion, affecting interactions with both immature
and mature thymocytes.
Discussion
During T cell development, bone marrow-derived pre-
cursors migrate towards the thymus. Developing thymo-
cytes travel within the cortex and medulla through cell-
cell and cell-extracellular matrix contacts and also in
response to soluble secretory moieties such as cytokines
and chemokines [1,2]. During this process, there is a
requirement of several time-dependent adhesion events
between thymocytes and cells of the thymic microenvir-
onment. Among the various molecular mechanisms
involved in such heterocellular adhesion, one is repre-
sented by fibronectin/integrin mediated interactions. In
particular, previous studies using anti-CD49e blocked
antibody have shown that such an adhesion is partially
under control of the FN/VLA-5 ligand/receptor pair
[4,13-15].
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Page 5 of 13Herein, we applied the RNA interference strategy to
silencing the CD49e gene, thus disrupting the integrin
VLA-5 in human thymic epithelial cells. Although being
transient, in most experiments we got a high efficiency
in abrogating the corresponding CD49e mRNA, as well
as its translation into the a5 integrin subunit (as ascer-
tained by its detection on the cell membrane). More-
over, the specificity of the siRNA knockdown of the
CD49e gene was ascertained by the fact that no effect
was seen with a scramble siRNA. Also, it is interesting
that the expression of CD49d (a4i n t e g r i ns u b u n i to f
the VLA-4 fibronectin receptor) quantified by a specific
antibody for the CD49d molecule using flow cytometry,
remained unchanged in CD49e-siRNA-treated TEC.
One could argue that another CD49d-containing integ-
rin, namely a4b7 integrin might be modulated by
CD49e knock down. However, this is not the case, since
the VLA-4 integrin (CD49d/CD29) is actually the only
CD49d-containing integrin constitutively expressed by
this human thymic epithelial cell preparation, as pre-
viously ascertained by immunoprecipitation and cyto-
fluorometry [35]. In a second vein, although the
expression of CD29 mRNA (the b1 subunit that forms
the various members VLA integrin sub-family) also
Figure 3 siRNA-induced knowndown of CD49e in cultured human thymic epithelial down-regulates other genes related to cell
adhesion. The expression of neuropilin-2 (Nrp2), vascular endothelial growth factor (VEGF) and plexin A mRNA are seen in the upper panels,
whereas neuronal cell adhesion molecule (NrCAM), and phosphatidylinositol-4-phosphate 5-kinase (PIP5K) are seen in bottom panels. In all cases,
real-time quantitative PCR was applied to compare CD49e-siRNA (black bars) with scramble-siRNA (open bars) treated human TEC. Analyses were
carried out 48 hours post-transfection. Results were normalized to b-glucuronidase mRNA and GAPDH mRNA and they are expressed relative to
the mRNA levels in CD49e-siRNA versus scramble-siRNA in transfected cells; results are representative of three independent experiments
performed in triplicate. Bars the mean values ± SE; and the data were validated using Mann-Whitney test (p ≤ 0.05).
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Page 6 of 13remain unchanged, we cannot discard the possibility
that other members of the VLA family (for example the
laminin receptor are modulated in this experimental
conditions. Yet, in any case, from a conceptual point of
view our findings unravel the independency of the regu-
lation of genes coding for different ECM receptors.
It should be point out, however, other molecules
related to cell adhesion/migration can be somewhat
under control of CD49e. In this respect, we found a
down-regulation of the gene coding for another adhesion
receptor, namely neuronal cell adhesion molecule
(NrCAM), which belongs to the L1 family of immunoglo-
bulin-like cell adhesion molecules, initially discovered in
nervous system [17]. In this regard, it is been described
that NrCAM interacts with various integrins including
a5b1, and that such interactions can support cell binding
and migration [18].
NrCAM is part of a growing list of “neural” molecules,
also including neuropilins, which are expressed in
immune systems, including the thymus [see reviews]
[19,20]. In addition to neuropilins, plexin A (that med-
iates neuropilin-induced intracellular signaling), and
VEGF, one of neuropilin natural ligands have been
described in the thymus [20]. In the human thymus,
neuropilins mediate thymocyte migration [19,20]. All
these genes are down-regulated following siRNA-
induced CD49e knockdown in human TEC, strongly
indicating the existence of a highly complex intracellular
molecular circuitry in the thymic epithelium, controlling
the expression of various genes involved in physiological
guidance of developing thymocytes within the thymic
lobules. It is conceivable that the mechanisms underlin-
i n gs u c hc o n t r o lm a yc o m p r i s ed i r e c ta sw e l la si n d i r e c t
effects of CD49e gene knockdown, as for example via
modulation of specific microRNAs that target those
genes, down- or up-regulated after CD49e silencing.
Dissecting this circuitry shall provide a much better
understanding of how the TEC network controls thymo-
cyte migration and adhesion. In a second vein, the
microarray analysis revealed that siRNA-induced knock-
down of CD49e in cultured human TEC also deregu-
lated the expression of signal transduction genes, some
of them related with intracellular pathways triggered by
integrins. The binding of fibronectin to a5b1 activates
two major tyrosine kinase-dependent pathways, the focal
adhesion kinase (FAK) pathway and the Shc pathway
[21]. FAK is recruited to the ligand binding site and
becomes activated through phosphorilation of tyrosine
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Transcription
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Figure 4 Classification of genes differentially expressed by human thymic epithelial cells after treatment with CD49e-siRNA versus
scramble-siRNA. The figure shows that most of genes up- or down-regulated in cultured human TEC under treatment with CD49e-siRNA (as
compared to scramble-siRNA) are not annotated. Yet, among the down-regulated genes with defined functions, 6% code for adhesion
molecules. Additionally, a large number of genes related to signal transduction was modulated in CD49e silenced TEC: among those genes
whose expression was down-regulated they represented 9%, and corresponded to 23% of the whole amount of up-regulated genes. The
classification of 65 down and 66 up-regulated genes in silenced cells to biological functions is given in left and right panels, respectively. The
classification into functional categories was defined according to the NCBI, SOURCE (http://smd.stanford.edu/cgi-bin/source/sourceSearch) and
DAVID (http://david.abcc.ncifcrf.gov/) databases.
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Page 7 of 13residues [22]. In turn, activation of FAK directly phos-
phorylates Src-family protein-tyrosine kinases [23].
Additionally, FAK can form an association with phos-
phatidylinositol 3-kinase (PI3K), and such an association
activates PI3K and its signaling pathways [24], regulat-
ing, among other functions, the actin cytoskeleton [25].
The regulation of actin fibers by PI3K can be mediated
by centaurin a-1, a phosphatidylinositol interacting pro-
tein, which directly interacts with F-actin, resulting in a
decrease in stress fibers, as ascertained in Hela cells
[26].
In our microarray data, we noticed that siRNA-induced
CD49e gene silencing in human TEC resulted in up-regu-
lation of the centaurin a-1 gene. Moreover, the down-reg-
ulation of phosphatidylinositol-4-phosphate 5-kinase type
I (PIP5K) mRNA, that is the predominant kinase that
synthesized phosphatidylinositol 4,5-bisphosphate [27,28]
also indicates a decrease in stress fibers in TEC with
CD49e knocked down. Although we have not directly
tackled this issue, such a decrease in F-actin could explain,
at least partially, the decrease in the ability of CD49e-
siRNA-treated TEC to promote thymocyte adhesion.
Among genes down-regulated in human cultured TEC
in which CD49e was knocked down by RNA interfer-
ence, we also found the activin receptor-like kinase 1
gene (acvrl1), which encodes a type I cell-surface recep-
tor (ALK1) for transforming growth factor-b1 (TGF-b1).
This cytokine is involved in the control of T cell devel-
opment through direct effect on both thymocyte and
epithelial cell compartments [29]. Thus, it is conceivable
that integrity of VLA-5 in human TEC is necessary to
maintain proper levels one TGF-b receptor, thus allow-
ing cross-talk between developing thymocytes and TEC.
Our results point some genes differential express due
the CD49e silencing, however we can’t discard the effect
of integrin crosstalk, a mechanism in which one integrin
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Figure 5 Decrease of thymocyte adhesion to human thymic epithelial cells following siRNA-induced knockdown of the CD49e gene.
Panel A depicts representative microscopic fields of human TEC cultures were transfected with scramble-siRNA or CD49e-siRNA, or that
remained untreated. Three days post-transfection thymocytes were led to adhere for one hour, being then fixed and were stained with Giemsa.
Adhered thymocytes (seen as darkly stained spots, arrows) were more numerous in untransfected cells and scramble-siRNA transfected cells,
when compared to CD49e-siRNA silenced cells. Original magnification X100. Such differences in the numbers of adhered thymocytes to TEC
were quantified and data are shown in panel B, in which the adhesion degree is plotted as association index, in which values correspond to
mean ± SE (see material & methods section). Differences were statistically evaluated by Student’s t-test. Data are representative of four separate
experiments and were significanly different between scramble-siRNA transfected cells versus CD49e-siRNA silenced cells. *p<0.02. Panel C reveals
that, the significant reduction in thymocyte adhesion comprises all CD4/CD8-defined thymocyte subsets, herein ascertained by cytofluorometry,
since their proportions are similar in the three conditions. For comparison, we also included the typical CD4/CD8 profile of human thymocytes
before co-culture. Lymphocyte gate was defined by side-scatter and forward scatter dot plots.
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Page 8 of 13regulates the activation state of a different integrin in
the same cell and this phenomenon involve the cytoske-
leton associated protein talin [36]. In addition, the integ-
rin crosstalk may be at the level of regulation the
stability of integrin subunit mRNA [37]. We are just
beginning to understand the molecular mechanisms that
are involved in regulating the activation state of integ-
rins and the molecular basis of crosstalk.
Finally, our data clearly show that knocking down the
CD49e in human TEC, using RNA interference, results in
a significant decrease in the ability of these cells to allow
thymocyte adhesion. Such a decrease comprised all CD4/
CD8-defined thymocyte subsets, a finding that is in accor-
dance with the data showing that variable amounts of
VLA-5 are expressed throughout the stages of intrathymic
T cell differentiation [11]. Whether other integrin-
mediated TEC/thymocyte adhesion interactions are also
modulated after CD49e gene knockdown (for example the
VLA-6/laminin binding) is presently under investigation.
Conclusion
In conclusion, the present study shows that siRNA-
mediated knockdown of the fibronectin receptor a5
integrin chain CD49e in human thymic epithelial cells
modulates, directly or indirectly, the expression of multi-
ple genes and decreases thymocyte adhesion. Among the
genes differentially expressed other cell adhesion related
molecules were down-regulated, including neuronal cell
adhesion molecule, neuropilin-2, plexin A and vascular
endothelial growth factor. Additionally, more than 130
genes are modulated in human TEC following knock-
down of CD49e. Some of these genes are related to intra-
cellular signaling pathways that can be triggered
following fibronectin binding to VLA-5. Conceptually,
these findings unravel the complexity of gene regulation,
as regards integrin-integrin crosstalk and key genes
involved in the heterocellular cell adhesion between
developing thymocytes and the major component of the
thymic microenvironment. At biological level, analyses of
the effects result from manipulation the expression of an
integrin subunit are complicated by the integrin crosstalk.
Further characterization of the relationship between these
genes and their corresponding proteins will offer a more
complete understanding of the cellular pathways affected
by CD49e gene knockdown and may lead to a better
comprehension of the tightly regulated process in which
different thymic microenvironmental cells, including
TEC, support interactions and signals required for the
proper intrathymic T cell development.
Methods
Thymus samples and thymic epithelial cell cultures
Surgical discarded thymic tissues were obtained from
children undergoing cardiac surgery, aged from 1 day to
3 years. Experimental procedures with human thymic
fragments have been approved by the Oswaldo Cruz
Foundation Ethical Committee for Human Research.
The human TEC line was obtained from an infant
thymus by an explant technique and limiting dilution
cloning [12], being kindly provided by Dr. Maria Luiza
Toribio (Universidad Autonoma de Madrid, Madrid,
Spain). TEC cells were cultured in 10% fetal bovine
serum-supplemented RPMI 1640 medium at 37°C in a
5% CO2 atmosphere.
CD49e (a5 integrin subunit) gene silencing
We used two siRNAs conjugated with alexa-488 (Qia-
gen, Hilden, Germany): a) unrelated siRNA, bearing the
same nucleotides, but scramble organized and not com-
plementary to any gene in mammals, b) specific CD49e-
siRNA, designed to specifically silence the expression of
CD49e. Semi-confluent cultures of human TECs cell
line were transiently transfected with 2.5 nM of CD49e-
siRNA or scramble-siRNA using Hiperfect reagent (Qia-
gen) in 24 well plates, following manufacturer’s
instructions.
After transfection, cells were cultured during 24 to 96
hours in RPMI medium as above mentioned. Transfec-
tion efficiency was confirmed by flow cytometry 24
hours after transfection. Gene knockdown was also con-
firmed by real-time quantitative PCR 48 hours after
transfection and protein silencing was confirmed by
immunohistochemistry and flow cytometry 72 hours
after transfection.
RNA Isolation and real-time quantitative PCR
Confluent TEC monolayers in 24 well plates untreated or
transfected with control scramble-siRNA or CD49e-
siRNA were dissociated in 1 ml of Trizol reagent (Invitro-
gen Life Technologies, Carlsbad, CA, USA) 48 hours after
transfection, according to the manufacturer’s instructions.
The isolated RNA was dissolved in diethyl-pyrocarbo-
nate-treated water and quantified by UV spectrophoto-
metry. We used only those DNA and phenol-free RNA
preparations. The integrity of RNA samples was evaluated
by conventional agarose gel electrophoresis.
Total RNA extracted from TEC was reverse tran-
scribed by using the Superscrit II reverse Transcriptase
kit (Invitrogen) following the manufacturer`s recommen-
dations. cDNA was diluted 1:5 in sterile water and used
for real-time quantitative PCR. Alternatively, the total
RNA was reverse transcribed and Cy3/Cy5 labeled by
using CyScribe Post-Labelling Kit (GE Healthcare)f o r
cDNA microarrays hybridizations.
Real-time quantitative PCR
The PCR primers were designed based on the sequences
reported in NCBI GenBank (http://www.ncbi.nlm.nih.
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(http://www.brothersoft.com/primer-premier-73311.
html) (Additional file 3). The prepared cDNAs were
amplified using Power SYBR Green Master Mix (PE
Applied Biosytems, Foster City, CA, USA)i na2 5 μL
reaction mixture in an ABI PRISM 7700 Sequence
Detection System (PE Applied Biosytems). All standard
dilutions were run in duplicate and the average value of
gene expression was used. Standard curves were
accepted when the slopes were between -3.74 and -3.32
(corresponding to PCR efficiencies of between 85 and
100%).
Primer pairs were evaluated for integrity by analysis of
the amplification plot, dissociation curves, and efficiency
of PCR amplification. For NrCAM, PIP5K and GAPDH
genes we used taqman probes, primers and Universal
Taqman Master Mix, all purchased from Applied
Biosystems.
PCR conditions were 10 minutes at 95°C, followed by
40 cycles of 15 seconds at 95°C and 60°C for 1 minute.
PCR amplification of the housekeeping gene encoding
b-glucuronidase was performed during each run for
each sample to allow normalization between samples.
Relative quantification and calculation of the range of
confidence was performed using the comparative δδCT
method.
cDNA microarray method
Gene expression of TEC transfected with control scram-
ble-siRNA or CD49e-siRNA was assessed using glass
slide cDNA microarrays, containing 4,500 sequences (in
replicates) from the human expressed sequence tags
(ESTs) cDNA library (IMAGE Consortium, http://image.
hudsonalpha.org). The microarrays were prepared based
on published protocols using 0.75-1.0 kb PCR product
f r o mt h ec D N Ac l o n e s[ 3 0 ] .T h em i c r o a r r a yw e r ec o n -
structed on silane-coated UltraGAPS slides (#40015,
Corning ®, New York, NY, USA) using a Generation III
array spotter (Amersham Biosciences Molecular
Dynamics Sunnyvale, CA, USA) according to the manu-
facturer’s instructions, and cross-linked using an ultra-
violet cross-linker. The cDNA complex probes were
prepared by reverse transcription using 10 µg of total
RNA from controls or CD49e silenced TECs which
were labeled using CyScribe post-labeling kit (GE
Healthcare), and oligo dT12-18 as a primer. The 15h
period of hybridization followed by washing was per-
formed in an automated slide processor (Amersham
Biosciences) and microarrays were scanned in a Genera-
tion III laser scanner (Amersham Biosciences). cDNA
complex probes from controls or CD49e silenced TECs
were Cy5-labeled. Cy3-labeled pool, consisting of equi-
molar amounts of total RNA from different human cell
lines (Jurkat, Hela, Hep-2 and U343), served as reference
in the two-color hybridizations. Microarrays raw signal
values as well as fold-change values for this entire data
set are publicly available at the National Center for Bio-
technology Information (NCBI) Gene Expression Omni-
bus (GEO) database, (GEO series accession no.
GSE18116 at http://www.ncbi.nlm.nih.gov/geo/).
Microarray statistical analysis
All analyses were performed using the freely available
statistical software and graphics R environment [31].
The “SPOT” software package (http://www.experimen-
tal.act.cmis.csiro.au/Spot/index.php) was used to identify
spots by adaptive segmentation method and subtract
backgrounds utilizing morphological opening approach.
Information thus recovered was analyzed using the
Limma package [32]. All data were normalized to
remove from the expression measures any systematic
bias which arise due to the microarray technology itself,
rather than differences between the probes or between
RNA samples targets hybridized to the arrays. This was
done by the print-tip Loess method which corrects for
dye bias and intensity within each group of adjacent
spots printed by one pin (print-tip). Spots that were too
small or large, based on its area, were kept in the analy-
sis but down-weighted. Differentially expressed genes
were ranked on Bayesian posterior log odds calculated
with Limma. The empirical Bayes method was used to
shrink the gene-wise sample variances towards common
values, thus augmenting the degrees of freedom for the
individual variances. This approach combines expression
ratios and their variability between replicates to rank the
genes [33]. Statistical significance between groups of
interest – scramble-siRNA versus CD49e-siRNA – was
assessed for relevant contrasts using moderated F statis-
tics as implemented in Limma package. In order to
determine which genes were significantly modulated by
CD49e-siRNA, we considered differentially expressed
genes according to the following contrast of interest:
CD49e-siRNA versus scramble-siRNA. We used Benja-
mini and Hochberg’s [34] method to control the false
discovery rate for the considered contrast.
Immunofluorescence
Slides containing untreated TEC, or cells treated with
CD49e-siRNA or corresponding scramble-control, were
washed with PBS/1% BSA. Samples were incubated with
anti-CD49e or anti-fibronectin (BD Biosystems, San
Diego, USA) overnight at 8°C, and then incubated with
s e c o n d a r ya n t i b o d yf o r3 0m i n u t e s ,u s i n gt h ea n t i -
mouse Ig conjugated to phycoeritrin for revealing the
anti-CD49e antibody and the rhodamine-couple anti-
rabbit IgG for detecting the anti-fibronectin reagent.
Immunostained samples were analyzed by confocal
microscopy using the Zeiss LSM 510 or LSM 5 Pascal
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were replaced by unrelated immunoglobulin was used
alone, and did not generate any significant labeling.
Cytofluorometry
Cytofluorometric analyses were performed using trans-
fected an untransfected TEC cell in different periods of
incubation, as well as adherent thymocytes. Following
24 hours of transfection TEC were washed and evalu-
ated for siRNA alexa-488 staining and after 72 hours of
transfection they were washed and staining with anti-
CD49e or anti-CD49d monoclonal antibodies that speci-
f i c a l l yr e c o g n i z et h eh u m a ncorresponding molecules.
Adherent thymocyte phenotyping was ascertained by
direct cytofluorometry, using anti-CD49e/PE, anti-CD4/
Percp and anti-CD8/APC monoclonal antibodies. All
antibodies were purchased from Pharmigen/BD Biosys-
tems). Cells were then evaluated by flow cytometer in a
FACSCalibur (BD Biosystems) and analyzed using the
CellQuest software (BD Biosystems).
Thymocyte-Thymic epithelial cell adhesion assay
Influences of CD49e gene knockdown upon thymocyte
interactions with thymic epithelial cells were tested
using RNA interference for CD49e in human thymic
epithelial cell line cultures. The ability of untreated or
siRNA transfected TEC to bind thymocytes was evalu-
ated by two distinct techniques. One approach was the
co-culture in the 24 well plate for phenotyping analysis
by flow cytometry of those thymocytes that remained
adhered on the TEC monolayer. We exposed TEC
monolayer to 50 thymocytes per TEC for one hour at
37°C in a 5% CO2 atmosphere, nonadherent thymocytes
were gently washed out, and adhered thymocytes har-
vested and phenotyped. Cells were washed and subse-
quently submitted to three-color immunofluorescence
staining as previously described [13]. A second approach
to evaluate thymocyte/TEC adhesion was by direct
counting, under the microscope, the numbers of thymo-
cytes which had adhered to TEC cultures. TECs were
trypsinized, replated to 8-well Labtek chambers (4 x 10
3
cells/0.5 ml in each chamber) for 12-18h, exposed to 50
thymocytes per TEC for one hour at 37°C in a 5% CO2
atmosphere, nonadherent thymocytes were gently
washed out, and coverglasses were fixed in cold absolute
ethanol for five minutes and stained with Giemsa or
used for immunoflurescence. Countings were integrated
in the form of an association index (AI) and calculated
using the following formula, previously validated for this
type of analysis [13-15]:
AI
number of TEC with thymocytes number of thymocytes boun
=
× d d to TEC
total TEC number
×100
At least 300 thymic epithelial cells with or without
adhered thymocytes, were counted per well. These
experiments were repeated at least three times, with two
separate observers performed counting blind. We did
not consider the growth rates, however, the evaluation
by two different observers after transfections did not
suggest any modifications in growth rates when com-
pared no treated with treated cells.
Additional material
Additional file 1: Table I: Classification of the down- and up-
regulated genes in siRNA-triggered CD49e silenced thymic
epithelial cells. List of genes differentially express with annotation.
Additional file 2: Tabel II: Down and upregulated genes in siRNA-
triggered CD49e silenced thymic epithelial cells without annotation.
List of genes differentially express without annotation.
Additional file 3: Table III: Oligonucleotide sequences specifically
tailored for used in real time PCR. GeneBank information and
oligonucleotide sequences used in real time PCR.
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